• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Replies
15
Views
1K
Replies
5
Views
659
Replies
34
Views
7K
Replies
33
Views
5K
Replies
5
Views
1K
Replies
23
Views
562
Replies
2
Views
241